View company's website
1 known investors
Aulos develops immune-activating antibody therapeutics for cancer treatment, using artificial intelligence to design monoclonal antibodies that modulate interleukin-2 activity to enhance immune activation in immuno-oncology.
AI & Machine LearningBiotechHealthtech